An atlas that catalogues gene activity and the levels of small molecules called metabolites in tumor samples offers a new way of identifying the deep mechanisms of cancer, according to researchers at Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center.
New MSK research identified a way to reduce toxicity in CAR T cell therapy; discovered a division of labor in DNA repair that suggests a…
July 12, 2023: International Precision Oncology Tumor Board – Targeting the BRAF Pathway: MSK & Sir HN Reliance Foundation Hospital Interpreting results from next-generation genomic…
Oncologist Luis Diaz Jr., at Memorial Sloan Kettering, achieved a breakthrough in cancer treatment. He focused on tumors with MMR deficiency.
Prophylactic subcutaneous administration of anakinra, an IL-1 receptor inhibitor, reduced severe immune effector cell-associated neurotoxicity syndrome incidence in patients with relapsed or refractory large B-cell…
Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments.
New MSK research discovered ferroptosis regulators that suggest therapeutic opportunities against hormone receptor-positive cancers; examined how tumor-associated macrophages might be turned against cancer; acquired new…
MSK has developed an arsenal of tests that are at the front lines of precision treatments. They target the structure of proteins that cause cancer,…
Over the last seven and a half decades, researchers at the Sloan Kettering Institute have made important contributions to the fundamental understanding of human biology,…
Over the last seven and a half decades, researchers at the Sloan Kettering Institute have made important contributions to the fundamental understanding of human biology,…
Cancer Straight Talk from MSK is a podcast about cancer that brings together patients and experts, to have straightforward evidence-based conversations. Memorial Sloan Kettering’s Dr.…
